Moreover, since autophagy inhibition (either by pharmacological or molecular approaches) potentiated the cytokilling effect of ALK inactivation (either by crizotinib treatment or by an ALK knockdown (KD) approach), our results established that autophagy represented a survival mechanism in therapeutically challenged ALK+ ALCL cells. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.